The pH-sensitive fusogenic 3-methyl-glutarylated hyperbranched poly(glycidol)-conjugated liposome induces antigen-specific cellular and humoral immunity

Clinical and Vaccine Immunology

Volumn 19, Issue 9, 2012, Pages 1492-1498

  Hebishima, Takehisa ^a,d   Yuba, Eiji ^c   Kono, Kenji ^c   Takeshima, Shin Nosuke ^a   Ito, Yoshihiro ^b   Aida, Yoko ^a  

^a Nano Medical Engineering Laboratory   (Japan)

^b RIKEN   (Japan)

^c Osaka Prefecture University   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYL GLUTARYLATED HYPERBRANCHED POLY(GLYCIDOL); DENDRITIC CELL VACCINE; DRUG CARRIER; GAMMA INTERFERON; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN FUNCTION; ANTIGEN PRESENTATION; ARTICLE; BLOOD SAMPLING; BONE MARROW; CELL PROLIFERATION; CELLULAR IMMUNITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; ENCAPSULATION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL PROLIFERATION; DRUG CARRIERS; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LIPOSOMES; MICE; MICE, INBRED C57BL; OVALBUMIN; SPLEEN; VACCINES;

EID: 84865966799     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00273-12     Document Type: Article

References (31)

1. Albert ML, Sauter B, Bhardwaj N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89. (Pubitemid 28150594)
2. Atif SM, et al. 2008. Sperm membrane lipid liposomes can evoke an effective immune response against encapsulated antigen in BALB/c mice. Vaccine 26:5874-5882.
3. Bungener L, et al. 2005. Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity. Vaccine 23:1232-1241. (Pubitemid 40126526)
4. Bungener L, et al. 2002. Virosome-mediated delivery of protein antigens to dendritic cells. Vaccine 20:2287-2295. (Pubitemid 34497039)
5. Chauhan A, et al. 2011. Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity. Vaccine 29:5424-5433.
6. Fenske DB, Chonn A, Cullis PR. 2008. Liposomal nanomedicines: an emerging field. Toxicol. Pathol. 36:21-29.
7. Fukasawa M, et al. 1998. Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes. FEBS Lett. 441:353-356. (Pubitemid 29065313)
8. Gregoriadis G, et al. 1999. Vaccine entrapment in liposomes. Methods 19:156-162. (Pubitemid 29497766)
9. Harokopakis E, Hajishengallis G, Michalek SM. 1998. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. Infect. Immun. 66:4299-4304. (Pubitemid 28402705)
10. Immordino ML, Dosio F, Cattel L. 2006. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomedicine 1:297-315.
11. Just M, Berger R, Dreschsler H, Brantschen S, Gluck R. 1992. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks. Vaccine 10:737-739.
12. Kono K, Zenitani K, Takagishi T. 1994. Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups. Biochim. Biophys. Acta 1193:1-9. (Pubitemid 24234171)
13. Kunisawa J, et al. 2001. Sendai virus fusion protein mediates simultaneous induction of MHC class I/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system. J. Immunol. 167:1406-1412. (Pubitemid 32703138)
14. Levine MM, Sztein MB. 2004. Vaccine development strategies for improving immunization: the role of modern immunology. Nat. Immunol. 5:460-464. (Pubitemid 38660452)
15. Murthy N, Robichaud JR, Tirrell DA, Stayton PS, Hoffman AS. 1999. The design and synthesis of polymers for eukaryotic membrane disruption. J. Control. Release 61:137-143. (Pubitemid 29406087)
16. Nakamura T, Moriguchi R, Kogure K, Shastri N, Harashima H. 2008. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes. Mol. Ther. 16:1507-1514.
17. Plotkin SA. 2005. Vaccines: past, present and future. Nat. Med. 11:S5-S11. (Pubitemid 40562297)
18. Reddy R, et al. 1991. pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. J. Immunol. Methods 141:157-163.
19. Reed SG, Bertholet S, Coler RN, Friede M. 2009. New horizons in adjuvants for vaccine development. Trends Immunol. 30:23-32.
20. Richards RL, et al. 1998. Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS, S malaria antigen. Infect. Immun. 66:2859-2865. (Pubitemid 28261796)
21. Sakaguchi N, Kojima C, Harada A, Kono K. 2008. Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH. Bioconjug. Chem. 19: 1040-1048. (Pubitemid 351748312)
22. Seki K, Tirrell DA. 1984. Interactions of synthetic-polymers with cell-membranes and model membrane systems. 5. pH-dependent complexation of poly(acrylic acid) derivatives with phospholipid vesicle membranes. Macromolecules 17:1692-1698.
23. Sharma SK, et al. 2006. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis. Vaccine 24:1800-1810. (Pubitemid 43238261)
24. Sharma SK, et al. 2006. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice. Vaccine 24:948-956. (Pubitemid 43185312)
25. Tachibana R, et al. 1998. Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking. Biochem. Biophys. Res. Commun. 251:538-544. (Pubitemid 28505058)
26. Therien HM, Lair D, Shahum E. 1990. Liposomal vaccine: influence of antigen association on the kinetics of the humoral response. Vaccine 8:558-562.
27. Yessine MA, Leroux JC. 2004. Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules. Adv. Drug Deliv. Rev. 56:999-1021. (Pubitemid 38520206)
28. Yoshikawa T, et al. 2006. Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma. Biol. Pharm. Bull. 29:100-104. (Pubitemid 43036703)
29. Yuba E, Harada A, Sakanishi Y, Kono K. 2011. Carboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomes. J. Control. Release 149:72-80.
30. Yuba E, Kojima C, Harada A, Tana Watarai S, Kono K. 2010. pH-sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity. Biomaterials 31: 943-951.
31. Yuba E, et al. 2008. Gene delivery to dendritic cells mediated by complexes of lipoplexes and pH-sensitive fusogenic polymer-modified liposomes. J. Control. Release 130:77-83.